ImmuCell Corporation (ICCC) Earnings History
Net Loss37 years of earnings data (1989–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
ImmuCell Corporation (ICCC) Earnings Overview
As of June 29, 2026, ImmuCell Corporation (ICCC) reported trailing twelve-month net income of -$545,403, reflecting +53.8% year-over-year growth. The company earned $-0.06 per diluted share over the past four quarters, with a net profit margin of -3.8%.
Looking at the long-term picture, ICCC's historical earnings data spans multiple years. The company achieved its highest annual net income of $2M in fiscal 2000.
ImmuCell Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PCRX ($9M net income, 1.0% margin), NEOG (-$609M net income, -122.1% margin), PAHC ($95M net income, 3.7% margin), ICCC has room to improve margins relative to the peer group. Compare ICCC vs PCRX →
ICCC Earnings vs Peers
Earnings metrics vs comparable public companies
ICCC Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$1M | +51.8% | $2M | $-0.12 | -3.8% | 6.0% |
| 2024 | -$2M | +62.7% | -$2M | $-0.26 | -8.1% | -6.2% |
| 2023 | -$6M | -131.5% | -$6M | $-0.75 | -33.1% | -32.9% |
| 2022 | -$2M | -3085.5% | -$2M | $-0.32 | -13.4% | -12.4% |
| 2021 | $-78,292 | +92.3% | $257,385 | $-0.01 | -0.4% | 1.3% |
| 2020 | -$1M | +21.1% | -$1M | $-0.14 | -6.7% | -9.0% |
| 2019 | -$1M | +44.2% | $-954,000 | $-0.19 | -9.4% | -7.0% |
| 2018 | -$2M | -1282.1% | -$1M | $-0.42 | -21.1% | -13.2% |
| 2017 | $-168,000 | -133.0% | $-243,000 | $-0.03 | -1.6% | -2.3% |
| 2016 | $508,448 | -58.1% | $890,204 | $0.12 | 5.3% | 9.3% |
| 2015 | $1M | +825.8% | $2M | $0.38 | 11.9% | 20.7% |
| 2014 | $-167,159 | -242.4% | $-206,398 | $-0.06 | -2.2% | -2.7% |
| 2013 | $117,395 | +31.2% | $-19,552 | $0.04 | 2.0% | -0.3% |
| 2012 | $89,512 | +121.9% | $245,000 | $0.03 | 1.7% | 4.5% |
| 2011 | $-409,510 | -6.5% | $-632,726 | $-0.14 | -8.0% | -12.4% |
| 2010 | $-384,684 | -77.7% | $-690,281 | $-0.13 | -8.8% | -15.7% |
| 2009 | $-216,493 | +53.8% | $-527,027 | $-0.07 | -4.8% | -11.7% |
| 2008 | $-468,557 | -170.8% | -$1M | $-0.16 | -10.1% | -25.2% |
| 2007 | $662,138 | +2.3% | $872,103 | $0.22 | 10.9% | 14.4% |
| 2006 | $647,137 | -8.6% | $770,681 | $0.21 | 13.5% | 16.1% |
| 2005 | $707,782 | +393.2% | $938,034 | $0.24 | 14.2% | 18.8% |
| 2004 | $143,519 | -65.1% | $120,771 | $0.05 | 3.9% | 3.3% |
| 2003 | $411,216 | -53.6% | $-429,031 | $0.15 | 12.2% | -12.8% |
| 2002 | $886,237 | +111.0% | $533,141 | $0.32 | 14.3% | 8.6% |
| 2001 | $420,000 | -81.1% | $671,000 | $0.15 | 6.3% | 10.0% |
| 2000 | $2M | +303.4% | $413,374 | $0.79 | 39.4% | 7.3% |
| 1999 | $550,843 | +650.8% | $614,970 | $0.22 | 11.2% | 12.5% |
| 1998 | $-100,000 | -133.3% | $0 | $-0.04 | -2.2% | 0.0% |
| 1997 | $300,000 | +400.0% | $300,000 | $0.10 | 6.5% | 6.5% |
| 1996 | $-100,000 | - | $-100,000 | $-0.04 | -2.3% | -2.3% |
| 1995 | $0 | +100.0% | $0 | $0.01 | 0.0% | 0.0% |
| 1994 | $-100,000 | - | $-300,000 | $-0.04 | -2.3% | -6.8% |
| 1993 | $0 | +100.0% | $-100,000 | $-0.01 | 0.0% | -2.6% |
| 1992 | $-200,000 | +85.7% | $-300,000 | $-0.11 | -6.5% | -9.7% |
| 1991 | -$1M | -133.3% | -$1M | $-0.69 | -63.6% | -63.6% |
| 1990 | $-600,000 | +40.0% | $-500,000 | $-0.28 | -20.0% | -16.7% |
| 1989 | -$1M | - | $-900,000 | $-0.50 | -35.7% | -32.1% |
Download Data
Export ICCC earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ICCC — Frequently Asked Questions
Quick answers to the most common questions about buying ICCC stock.
What is ICCC earnings per share (EPS)?
ICCC trailing twelve-month (TTM) diluted EPS is $-0.06, reflecting +53.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is ImmuCell Corporation's net income?
ImmuCell Corporation (ICCC) trailing twelve-month net income is $-545403.00 as of 2025. Earnings grew +53.8% year-over-year.
Is ICCC profitable?
ICCC is not currently profitable on a TTM basis, reporting a net loss of $-545403.00. Net margin is -3.8%. Investors should monitor for a return to profitability.
What is ICCC's earnings growth rate?
ICCC compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are ICCC's profit margins?
ImmuCell Corporation net profit margin is -3.8%, operating margin is +6.0%, and gross margin is +41.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -3.8%.
Is ICCC growing earnings?
Yes, ICCC earnings are accelerating — EPS growth of +53.8% exceeds the 5-year CAGR of N/A. TTM net income reached $-545403.00. Earnings momentum is strengthening.
What was ICCC's best earnings year?
ImmuCell Corporation's highest annual net income on record is $2M, achieved in fiscal year 2000. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were ICCC's earnings last quarter?
ICCC's most recent reported quarter was Q1 2026. Net income was $2M with diluted EPS of $0.21. For a full breakdown of all quarters, see the quarterly earnings table on this page.